Laurion Capital Management LP Alnylam Pharmaceuticals, Inc. Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$121.19 - $165.49 $728,715 - $995,091	-6,013 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$104.21 - $156.44 $626,614 - $940,673	6,013 New	6,013 $891,000
Q1 2019 May 08, 2019	SELL	$72.76 - $93.45 $679,651 - $872,916	-9,341 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$62.67 - $88.33 $585,400 - $825,090	9,341 New	9,341 $681,000
Q1 2018 May 14, 2018	SELL	$115.92 - $148.54 $14.1 Million - $18.1 Million	-121,735 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$114.49 - $139.98 $13.9 Million - $17 Million	121,735	121,735 $15.5 Million

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.